| Literature DB >> 33999864 |
Daniel L Neuman1, Andrea L Chadwick.
Abstract
Burning mouth syndrome is a chronic pain condition characterized by a burning sensation of the oropharynx. The pathophysiology of burning mouth syndrome includes peripheral and central sensitization. Treatment is generally aimed at symptom reduction. We describe a woman in her seventh decade with burning mouth syndrome that had been refractory to treatment for nearly a decade. Low-dose naltrexone has been reported to provide analgesia in central sensitization states and was successful in reducing pain severity in our patient. We conclude that low-dose naltrexone may be a therapeutic option for patients with burning mouth syndrome who are refractory to conventional therapies.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33999864 PMCID: PMC8311810 DOI: 10.1213/XAA.0000000000001475
Source DB: PubMed Journal: A A Pract ISSN: 2575-3126